Forget WELL Health (TSX:WELL): Here’s an Overlooked Telehealth Stock

WELL Health (TSX:WELL) stock has a hidden rival that investors should be aware of.

| More on:
healthcare pharma

Image source: Getty Images

WELL Health Technologies (TSX:WELL) has been one of the best tech stocks of 2020. It’s up 351% year to date, beating out larger, better-known tech companies in terms of total returns. However, there’s a secret rival that could steal some of WELL Health’s glory and dash investor expectations. 

If you’re looking for a telehealth bet or already own WELL Health stock like me, here’s what you need to know. 

Telehealth rival

Despite its size and potential, WELL Health’s closest rival rarely gets mentioned: Telus Health. Part of Telus (TSX:T)(NYSE:TU), Telus Health offers many of the same features and benefits as its smaller counterpart. However, this company is backed by one of the largest telecommunications firms in the country. 

Telus Health offers medical data software for clinics, digital tools for insurance companies, pharmacy management software and, of course, a virtual clinic called Telus Babylon. However, Telus Health has one big competitive advantage: control of distribution. 

Control of distribution makes a major difference in the tech industry. After all, Telus could certainly offer its healthcare applications and services along with the broadband and wireless plans that millions of businesses and individuals already sign up for. That key differentiator could make Telus Health a major threat to WELL Health. 

WELL Health’s stock valuation

WELL Health is currently worth $1.1 billion. Meanwhile, the company generated $42.8 million in revenue over the past 12 months. That means WELL Health stock is trading at a price-to-sales ratio of 26. 

By conventional measures, WELL is overvalued. The company needs to deliver on astounding growth expectations to justify this valuation. 

Meanwhile, Telus Health is a private subsidiary of Telus Corp. If the parent company decides to spin off the Healthcare division, it could be worth considerably more than WELL Health. 

Nevertheless, Telus stock is still a proxy for investors who want exposure to the telehealth market without the risk and volatility. Telus stock trades for 24.4 times earnings and offers a juicy 4.87% dividend yield. If the company decides to spin-off this segment in the future, I have no doubt it could create a windfall for shareholders. 

Bottom line

WELL Health stock has dominated the headlines for much of this year. The stock has climbed faster than most other tech stocks in just a few months. It’s still got plenty of room left to grow. 

However, investors are missing out on a hidden rival. Telus could have just as many (if not more) users of its apps and services as WELL. Investors looking for a conservative way to bet on the telehealth industry could add this stock to their portfolio. 

To be clear, the global healthcare technology and telehealth sector is big enough to accommodate many players. Both stocks mentioned here could be successful over the long run. So, it might be a good idea to bet on the one that fits your investment style.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL. The Motley Fool recommends TELUS CORPORATION.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »